Search - tctmd.com

Displaying 21 - 40 of 42

Sort: Relevancy | Date

Presentation BRS 2014

MSCT for Pre-Procedural Lesion Characterization and Polymer BRS Follow-Up

Presenter: Yoshinobu Onuma

July 25, 2014

Presentation TVT 2014

When Should Echocardiography be a Surrogate Alternative or Preferred for TAVR Sizing?

Presenter: Rebecca T. Hahn

June 07, 2014

Presentation TVT 2014

CT Valve Sizing for the Lotus TAVR System

Presenter: Ian T. Meredith

June 07, 2014

Presentation TVT 2014

CT Valve Sizing for the Portico Self-Expanding TAVR System

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

SAPIEN 3 Sizing Considerations: The Concept of True Sizing and Balloon-Volume Reduction

Presenter: John G. Webb

June 07, 2014

Presentation TVT 2014

CT Valve Sizing Algorithms for the CoreValve Self-Expanding Valve: Lessons from the US CoreValve Experience

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

CT Valve Sizing Algorithms for the SAPIEN Balloon-Expandable Valve: Methodology and Guidelines

Presenter: Jonathon A. Leipsic

June 07, 2014

Presentation TVT 2014

MSCT Essentials and Pitfalls What EVERYONE MUST KNOW!

Presenter: Jonathon A. Leipsic

June 07, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

Presentation CTO 2014

IVUS and MSCT Lessons for Procedural Planning

Presenter: Yves R. Louvard

February 27, 2014

Presentation

Aortic MSCT for TAVI Assessment

Presenter: Bernard Chevalier

December 02, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by MSCT (with Case Vignettes)

Presenter: James Min

October 30, 2013

Presentation TCT 2013

Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Jonathon Leipsic

October 28, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

Presentation TCT 2013

Rotational angiography with 3D reconstruction following motion field estimation for evaluation of geometry of the implanted Medtronic Corevalve frame: comparison with MSCT

Presenter: Carl Schultz, Peter De Jaegere, Nicolas Van Mieghem

January 31, 2013

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

Presentation TVT 2012

Snapshot I. Annulus Sizing: 3-D MSCT Is Now the "Gold Standard"

Presenter: Jonathon Leipsic

June 03, 2012

Presentation TVT 2012

MSCT Should Be the 'Gold Standard' for Valve Sizing Strategies

Presenter: Jonathon Leipsic

June 03, 2012

Presentation CTO 2012

Utility of MSCT in Planning CTO Revascularization

Presenter: Satoru Sumitsuji

February 23, 2012

Advertisement

MSCT for Pre-Procedural Lesion Characterization and Polymer BRS Follow-Up

When Should Echocardiography be a Surrogate Alternative or Preferred for TAVR Sizing?

CT Valve Sizing for the Lotus TAVR System

CT Valve Sizing for the Portico Self-Expanding TAVR System

SAPIEN 3 Sizing Considerations: The Concept of True Sizing and Balloon-Volume Reduction

CT Valve Sizing Algorithms for the CoreValve Self-Expanding Valve: Lessons from the US CoreValve Experience

CT Valve Sizing Algorithms for the SAPIEN Balloon-Expandable Valve: Methodology and Guidelines

MSCT Essentials and Pitfalls What EVERYONE MUST KNOW!

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

IVUS and MSCT Lessons for Procedural Planning

Aortic MSCT for TAVI Assessment

Vulnerable Plaque Diagnosis by MSCT (with Case Vignettes)

Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

Rotational angiography with 3D reconstruction following motion field estimation for evaluation of geometry of the implanted Medtronic Corevalve frame: comparison with MSCT

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Snapshot I. Annulus Sizing: 3-D MSCT Is Now the "Gold Standard"

MSCT Should Be the 'Gold Standard' for Valve Sizing Strategies

Utility of MSCT in Planning CTO Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content